Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Endocrinology|November 8, 2012
Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegalyJohan Verhelst, Brigitte Velkeniers, Dominique Maiter, et al.
Clinical Endocrinology|September 18, 2010
A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemiaFadil M Hannan, M A Nesbit, Paul T Christie, et al.
Frontiers in Oncology|May 24, 2021
Endoscopic, Endonasal Transsphenoidal Surgery for Tumors of the Sellar and Suprasellar Region: A Monocentric Historical Cohort Study of 369 PatientsLaura Van Gerven, Zhen Qian, Anastasiya Starovoyt, et al.
Frontiers in Endocrinology|March 3, 2020
Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin AnalogsMônica Gadelha, Marie Bex, Annamaria Colao, et al.
Frontiers in Endocrinology|September 8, 2023
Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extensionMônica Gadelha, Peter J Snyder, Przemysław Witek, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2008
GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in plateletsKathleen Freson, Benedetta Izzi, Veerle Labarque, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 26, 2022
[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patientsElin Pauwels, Sofie Celen, Kristof Baete, et al.
Endocrine-Related Cancer|May 6, 2022
Exploring stem cell biology in pituitary tumors and derived organoidsCharlotte Nys, Yu-Lun Lee, Heleen Roose, et al.
Pituitary|November 20, 2020
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndromeEliza B Geer, Roberto Salvatori, Atanaska Elenkova, et al.
Frontiers in Endocrinology|October 25, 2023
Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's diseaseRichard A Feelders, Maria Fleseriu, Pinar Kadioglu, et al.
Pageof 3